$DXCM insider trading

Over the last 12 months, Dexcom insiders reported no purchases and 9 sales totaling $7.5M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.

$7.5M
9
4
100%
Side
$100K$1.0M$10MMay '26JunJulAug
SAYER KEVIN R
Brown Michael Jon
FOLETTA MARK G
Coleman Jon

All insider trades

Aug 3, 2026FOLETTA MARK G▼ Sale4,000$82.66$331K-7.6%
Jul 20, 2026SAYER KEVIN R▼ Sale26,756$76.32$2.0M-7.5%
Jul 15, 2026Brown Michael Jon▼ Sale1,700$74.42$127K-1.6%
Jul 6, 2026SAYER KEVIN R▼ Sale26,756$72$1.9M-7%
Jun 15, 2026Brown Michael Jon▼ Sale1,700$75.55$128K-1.6%
Jun 15, 2026FOLETTA MARK G▼ Sale4,000$74.13$297K-7%
Jun 4, 2026Coleman Jon▼ Sale4,911$74.13$364K-4.9%
Jun 3, 2026Coleman Jon▼ Sale4,912$73$359K-4.7%
May 21, 2026SAYER KEVIN R▼ Sale26,759$72$1.9M-6.5%

Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $DXCM feed.

DXCM Insider Trading — Form 4 Buys & Sells | alphai